An in-depth analysis of young people's experience of their juvenile idiopathic arthritis (JIA) once receiving Etanercept
Main Authors: | Livermore P, Woo P, Wedderburn LR |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-09-01
|
Series: | Pediatric Rheumatology Online Journal |
Similar Items
-
Open label multicenter study of once weekly Etanercept 0.8 mg/kg in active polyarticular Juvenile idiopathic arthritis (JIA)
by: Horneff G, et al.
Published: (2008-09-01) -
14.4 Oligoarticular Juvenile Idiopathic Arthritis (JIA): can extension be predicted?
by: Hunter PJ, et al.
Published: (2008-09-01) -
Multicentric Castleman's Disease (CD) in juvenile idiopathic arthritis (JIA) treated with etanercept: coincidence or causal relationship?
by: Rossi L, et al.
Published: (2008-09-01) -
Etanercept in juvenile idiopathic arthritis: Who will benefit?
by: van den Berg JM, et al.
Published: (2011-09-01) -
Challenges in the management of juvenile idiopathic arthritis with etanercept
by: Clare E Pain, et al.
Published: (2009-03-01)